Previous studies have demonstrated that NLRP3 is associated with susceptibility to inflammatory bowel disease (IBD) while also regulating intestinal homeostasis through control over intestinal epithelial integrity, microbiota composition, and immune response (53, 54). Here, NLRP3 is linked to inflammatory bowel disease.